The Side Effects and Potential Dangers of Traditional Flea and Tick Preventatives in Dogs
Flea and tick preventatives are crucial for maintaining the health and well-being of our canine friends, including breeds such as Dobermans. However, it's important for pet owners to be aware of the potential side effects associated with traditional preventatives. Our goal is not to discourage preventive use, but to help Doberman guardians make more informed decisions.
-
The Concerns with Traditional Preventatives
Increase in Scrutiny and Lawsuits over Adverse Reactions
Some Topicals Do Not Prevent Tick Bites
Concerns over PFAs
Long-Term Data Issues
Dobermans
Common Flea and Tick Medications
What's Inside The Treatments?
Fipronil
Imidacloprid
Pyrethroids (e.g., Permethrin)
Isoxazolines (e.g., Fluralaner, Afoxolaner, Sarolaner)
Selamectin
Spinosad (fleas only)
Flumethrin
Side Effects That Shouldn’t Be Ignored
Absorption Routes - A List
Clearly systemic topicals
Primarily skin/localized topicals
Mixed topical
Oral/systemic chewables
Information on Tick Kill Times
More Legal Battles
Special Note on Dobermans
FDA & EPA Oversight and Safety Measures
Research Conflict of InterestsExploring Safer Alternatives
The Concerns with Traditional Preventatives
Increase in Scrutiny and Lawsuits over Adverse Reactions
Frontline, Advantix & Seresto
Several brands, including Frontline, Advantix, and Seresto, have been under scrutiny due to reports of adverse reactions in dogs. These reported adverse reactions can range from minor skin irritations to severe neurological problems.
Most notably, a class action lawsuit over Seresto flea and tick collars (containing imidacloprid and flumethrin) was settled for $15 million in 2024–2025. The settlement provides compensation for purchasers and those reporting pet injuries or deaths, though the manufacturers (Elanco and Bayer) did not admit liability.
→ You can read a summary of this settlement [here].
Bravecto, Nexgard & Simparica
Moreover, isoxazoline-based products like Bravecto, Nexgard, and Simparica have been linked to neurological issues, as highlighted by an FDA fact sheet. Skin irritation, vomiting, diarrhea, and neurological issues such as seizures have been reported.
Other actions have targeted older topical "spot-on" treatments (like Frontline, Advantage/K9 Advantix, and various Hartz/Sergeant’s products) and oral isoxazoline-class medications (such as Bravecto, NexGard, and Simparica). The spot-on lawsuits, filed around 2010 amid high adverse-event reports, saw some claims narrowed or dismissed, but contributed to enhanced EPA labeling requirements. Isoxazoline products have faced class actions and FDA alerts over potential neurological side effects; while many claims have advanced only partially and the products remain on the market with updated warnings, these cases continue to fuel ongoing consumer discussions.
→ Find the 2023 FDA Fact Sheet for Isoxazoline Flea and Tick Products [here], and FDA Animal Drug Safety Communication issued in 2019 [here].
Important: It's vital for dog guardians to monitor their dogs closely after administering these treatments and to consult a veterinarian immediately if any adverse reactions occur.
Some Topicals Do Not Prevent Tick Bites
Another concern is that according to the Cornell Richard P. Riney Canine Health Center, “Topical products with fipronil (e.g. Frontline) do not repel or prevent tick attachment, which means you may still see ticks crawling on your pet. It will not kill ticks until after attachment for 24 hours.”. This situation matters because in dogs, some tick-borne infections can start being transmitted within about 3 to 6 hours of tick attachment, especially Ehrlichia spp. and Rickettsia spp. In contrast, Lyme disease caused by Borrelia burgdorferi usually requires about 24 to 48 hours of feeding, and anaplasmosis is also commonly cited as requiring about 24 to 48 hours of attachment before transmission.
Concerns over PFAs
A June 2021 press release from PEER and the Center for Biological Diversity reported that laboratory testing detected PFAS in several popular flea and tick products, including a topical treatment and a flea collar, and argued that this raises added concerns for both pets and the people who handle them. The groups criticized the EPA for weak oversight, pointing to broader concerns about pesticide regulation, undisclosed ingredients, and prior adverse event reports involving Seresto collars. They also emphasized that PFAS are persistent chemicals with potential health risks and argued that exposure through routine contact with treated pets, especially among children, warrants far more regulatory scrutiny.
Long-Term Data Issues
Arguably, the long-term compounding effect of these chemicals is not well understood. Among dog spot-on topicals, to our knowledge, the longest overall published study window exists for the imidacloprid 10% and permethrin 50% spot-on formulation, which corresponds to the Advantix formulation family. In this longitudinal field study, dogs were treated on day 0 and every 21 ± 2 days, with sampling at baseline in March-April 2008, then July 2008, October 2008, April 2009, and an additional untreated follow-up in October 2009. That works out to roughly 12 months of repeated treatment and roughly 18 months total observation from baseline to the last sample. Advantix is an authorized spot-on dog product containing permethrin and imidacloprid.
Given that guardians may give their dogs flea and tick preventives for years, if not their lifetimes, the uncertainty matters because what is often treated as ‘long-term’ safety data in clinical research may still rest on relatively short observation periods, as shown by the 18-month window. Authoritative sources [CIOM; FDA; National Academies] have cautioned that studies conducted for too short a duration systematically underestimate long-term effects, and that preapproval trials often provide limited information about long-term exposure because of their short duration and practical design constraints.
Dobermans
Particularly medically sensitive breeds like Dobermans (Dobermans carry an, what some would call unusually heavy burden of serious breed-associated disease across multiple organ systems (e.g., cardiac and, in possible connection, thyroid), plus at least one documented breed-linked drug hypersensitivity) may warrant that guardians need a more in-depth risk-benefit and product choice discussion with their veterinarian.
Public Group Reporting
Many dog guardians have shared their observations of adverse reactions on social media. If you are interested in learning about pet owners’ experiences with what they describe as negative side effects or suspect that any, for example, isoxazoline-based products have affected your pet, you may wish to join this Facebook group.
→ Cave: Please be advised that personal accounts of perceived adverse reactions do not, on their own, equal proof of causality. Hence, we would strongly caution against jumping to conclusions; discuss your concerns with a veterinarian who is open to discussion and investigation.
The ADW Concept Store - Discover ADW’s Creative Vision
Common Flea and Tick Medications
Flea and tick preventatives come in various forms, including spot-on treatments (Frontline Plus, Advantix), oral medications (Bravecto, Nexgard), collars (Seresto), and sprays. They're designed to kill or repel pests, but the difference lies in their application and active ingredients. Understanding these can help you make informed decisions about your pet's care.
What's Inside The Treatments?
The majority of these products contain chemicals like Fipronil, Imidacloprid, Pyrethroids (e.g., Permethrin), and Isoxazolines (e.g., Fluralaner). As Stephen Page mentions for Fipronil in the 2008 published textbook, “Small Animal Clinical Pharmacology’, these compounds were originally developed for agriculture and pest control, and disrupt the nervous system of insects, leading to their death. While labeled as effective and deemed much less toxic to mammals than insects, their use and potential effects in environments beyond our pets' coats, such as in our homes and gardens, still may raise questions about their overall safety and environmental impact.
→ Note: A newly published 2026 review article proposed that some veterinary antiparasitic classes, specifically neonicotinoids, isoxazolines, avermectins, and pyrethroids, may potentially access the central nervous system through retrograde axonal transport from peripheral nerves rather than only through blood-brain barrier penetration. The authors also discussed whether PFAS in formulations could theoretically contribute to this process or add to neurotoxic burden, while emphasizing that these mechanisms remain hypothetical and still require direct experimental confirmation.
1. Fipronil
Side Effects in Dogs: Irritation at the application site, reduced appetite, excessive salivation, and, in case of toxicosis, seizures.
→ Find a more comprehensive adverse reaction analysis [here].
→ Emerging research has also begun to investigate the effects Fipronil might have on mammals, including dogs, on emotional and cognitive behaviors.Other Uses: Used in agriculture and in household products for pest control.
Products Containing Fipronil: Frontline Plus (dogs), Frontline Spray, and various generic versions.
→ Pharmacology note: “Fipronil is not thought to be significantly absorbed from topical sites of application but to translocate dermally, being confined to the lipids of hair follicles and sebaceous glands.” Thus, while pharmacological research argues against major systemic absorption, there may still be questions about (long-term) dermal translocation (often, the recommendation for topicals is year-round, monthly application) and adverse reactions.
More on the systemic absorption of topicals follows below.
2. Imidacloprid
Side Effects in Dogs: Skin irritation, vomiting, diarrhea, and lethargy.
→ Find more information on oral Imidacloprid side-effects [here].
→ Find more information on topical Imidacloprid side-effects [here].Other Uses: Employed in agriculture for pest control and in household pest products.
Products Containing Imidacloprid: Advantage II (dogs), Advantix II (dogs – note: this product should not be used on cats), and Seresto collars.
→ Note: Some research cautions that when used as a topical, “repeated chronic exposure to imidacloprid may pose possible health risks to veterinarians, veterinary technologists, dog caretakers, and owners.”
3. Pyrethroids (e.g., Permethrin)
Side Effects in Dogs: Skin irritation, trembling, and vomiting, and, in case of toxicosis or sensitivity, seizures.
Other Uses: Used in insecticidal sprays, mosquito repellents, and agricultural products.
Products Containing Pyrethroids: K9 Advantix II (dogs only), various flea and tick sprays, and yard sprays.
→Note: Products containing permethrin are extremely toxic to cats and fish.
4. Isoxazolines (e.g., Fluralaner, Afoxolaner, Sarolaner)
Side Effects in Dogs: Vomiting, diarrhea, lethargy, appetite loss, and, when given as a chewable, rare seizures.
Other Uses: Mainly used in veterinary medicine for treating fleas and ticks.
Products Containing Isoxazolines: Bravecto (Fluralaner), Nexgard (Afoxolaner), and Simparica (Sarolaner).
5. Selamectin
Side Effects in Dogs: Temporary hair loss (cats) or hair clumping (dogs), skin irritation, vomiting, diarrhea, and, in very rare cases, seizures.
Other Uses: Primarily used in veterinary settings for treating parasites in domestic animals.
Products Containing Selamectin: Revolution (dogs) and various generic versions.
6. Spinosad (fleas only)
Side Effects in Dogs: Vomiting, diarrhea, skin irritation, and rare seizures.
Other Uses: Utilized in agriculture to control pests and considered an eco-friendly alternative to traditional pesticides.
Products Containing Spinosad: Comfortis (dogs) and Trifexis (also contains milbemycin oxime for heartworm prevention).
7. Flumethrin
Side Effects in Dogs: May include skin irritation, lethargy, vomiting, and in rare cases, neurological issues such as tremors or seizures.
Other Uses: Flumethrin is primarily used in veterinary medicine but is also employed in the agriculture sector to control ticks and other pests in cattle.
Products Containing Flumethrin: It is found in the Seresto collar (combined with Imidacloprid), used for dogs and cats to prevent flea and tick infestations.
→Note: For references, see Seresto Collar, since there is no clean data for Flumethrin alone in this context.
Side Effects That Shouldn’t Be Ignored
While many dogs may tolerate flea and tick medications well, adverse reactions can and do occur. The severity can vary from mild discomfort to life-threatening conditions. Detailed statistics and studies have shown a range of reactions, emphasizing the need for vigilance and prompt veterinary care if adverse effects are observed.
Absorption Routes - A List
Conventional flea and tick preventives are often discussed as though they all behave the same way once they are put on the dog. They do not. Even within the category of topicals, some products are designed to remain primarily on the skin, hair coat, and sebaceous layer, some are clearly absorbed and circulate systemically, and some sit somewhere in between. We are providing the list below because that distinction matters when people are trying to understand how a given product works, what kind of exposure it creates, and why two “topical” products should not automatically be treated as interchangeable. EPA and FDA themselves have acknowledged that the old shorthand of “topicals stay on the skin, oral products are systemic” no longer cleanly reflects reality.
→ Note: This list is a classification aid, not a verdict. The list is based on publicly available label language, mechanism descriptions, and pharmacokinetic information. It is meant to clarify whether a product appears primarily localized, clearly systemic, or mixed in its behavior after application. “Primarily localized” should not be read as “zero absorption,” and “systemic” should not be read as a synonym for “unsafe.” The point is narrower and more useful: route of administration alone does not tell you enough, and topical products should be evaluated according to how they actually behave in the body and your dog’s circumstances, not how they are grouped.
Clearly systemic topicals
Revolution (selamectin): after spot-on administration, selamectin is absorbed from the skin, reaches plasma concentrations, and then distributes systemically in dogs and cats
Revolution Plus (selamectin + sarolaner): both actives are well absorbed after topical administration and distribute systemically.
Bravecto topical for dogs: fluralaner reaches peak concentrations after topical administration, and the label states that fluralaner is for systemic use.
Primarily skin/localized topicals
Frontline Plus for dogs: it localizes in the hair, on the skin surface, and in the sebaceous glands, which act as a reservoir; fleas and ticks are killed after contact and do not need to bite.
Frontline Gold for dogs: it spreads from the application site, localizes in the hair, on the skin surface, and in the sebaceous glands, and those glands act as a reservoir.
Frontline Shield for dogs: it is described as being stored in the sebaceous glands and spreading over the whole-body surface with natural oils; fleas and ticks are killed through contact and do not need to bite.
K9 Advantix II for dogs: it is applied to the skin, spreads over the dog’s body, and kills fleas, ticks, and mosquitoes through contact rather than requiring a bite.
Advantage II / imidacloprid-only spot-ons: topical imidacloprid is distributed across the skin by translocation and can be found in hair follicles, shed hair, and sebum; in dogs, systemic absorption appears minimal to none. The Advantage II label also describes it as starting to work through contact.
Mixed topical
Advantage Multi for dogs: this is the in-between one. In the corresponding imidacloprid/moxidectin dog spot-on formulation, imidacloprid is rapidly distributed over the skin and remains on the body surface, while moxidectin is absorbed through the skin and distributed systemically.
Vectra 3D for dogs: This product is best classified as mixed rather than purely localized. According to the product information, dinotefuran and pyriproxyfen are partially absorbed through the skin, leading to systemic exposure, while permethrin plasma levels remain under the limit of quantification. At the same time, the actives also distribute over the body surface and are described as acting directly on the coat.
Seresto (imidacloprid + flumethrin collar)
Seresto fits best in the primarily skin/localized category. The EPA-approved label states that the collar’s active ingredients, imidacloprid and flumethrin, are slowly and continuously released from the collar toward the animal and spread from the site of direct contact over the skin surface.
A public German regulatory assessment reached the same basic conclusion. It states that both active ingredients are slowly and continuously released from the collar and reach insecticidal and acaricidal concentrations on the animal’s body surface during the efficacy period.
→ Note: At the same time, Seresto should not be described as purely non-systemic. The same German assessment reports that imidacloprid was transiently found in low plasma concentrations in cats and dogs wearing the collar, while flumethrin was not detectable in plasma. For that reason, the most defensible classification is: Seresto is primarily cutaneous/localized, with limited systemic exposure rather than clear systemic distribution.
Oral/systemic chewables
NexGard (afoxolaner): This is an oral chewable, not a topical. After oral administration in dogs, afoxolaner shows high systemic absorption. Official product information states that NexGard kills fleas within 8 hours and ticks within 48 hours.
NexGard PLUS (afoxolaner + moxidectin + pyrantel): This is an oral chewable, not a topical. Official product information states measurable plasma concentrations for afoxolaner and moxidectin after oral administration. For ticks, official product information also supports kill times of about 48 to 72 hours, depending on the tick species.
Information on Tick Kill Times
According to Cornell Vet school, Seresto collars and some topical permethrin products repel ticks and prevent attachment. Fipronil, as mentioned, does not repel ticks and may not kill them until after 24 hours. Oral isoxazolines do not prevent attachment but kill ticks quickly. As such, knowing the pathogens ticks transmit in your area and the respective transmission times for those pathogens (as discussed above) can help to narrow down further which preventive product to use.
More Legal Battles
As aforementioned, there have been numerous lawsuits against manufacturers of traditional chemical-based flea and tick products, often centered on allegations of neurological issues (such as seizures, tremors, or ataxia), skin reactions, organ damage, or even pet deaths. These cases typically claim inadequate warnings or product defects. While outcomes vary—many involve partial dismissals, private resolutions, or no admission of wrongdoing—they have sometimes prompted label updates, usage guideline changes, or regulatory scrutiny, underscoring the need for pet owners to follow instructions carefully and consult veterinarians.
→ Find a 2010 overview of past lawsuits [here]
Regulatory efforts, such as those by the NRDC leading to warning labels or phase-outs of certain older collar ingredients (e.g., propoxur), have also driven safety improvements.
→ Find more information [here]
Special Note on Dobermans
Certain breeds, such as Dobermans, may be predisposed, making them potentially more vulnerable to side effects from these preventives. Since Dobermans can be prone to several specific skindisorders, topical application may be especially troublesome for some. This heightened sensitivity may necessitate a careful approach, emphasizing the need for breed-specific guidance on which product may be most appropriate and, if not, alternative treatments are an option. Speak to your veterinarian familiar with the breed before making any decisions on topicals or chewables for treating your dog.
FDA & EPA Oversight and Safety Measures
The U.S. Environmental Protection Agency (EPA) regulates most topical flea and tick products, although some have been approved by the FDA, ensuring they meet safety standards before reaching the market. Moreover, the FDA has, on average, regulated flea and tick chewables. However, the approval process, including the studies and trials supporting these products, often relies on data from pharmaceutical companies, which can create potential conflicts of interest. Understanding the EPA's role and the limitations of regulatory oversight can help pet owners make more informed choices.
→Note: Historically, EPA and FDA split oversight of topical flea/tick products based on whether the active remained on the skin or was systemically absorbed into the bloodstream.
Research Conflict of Interests
While not inherently an issue, the scientific evidence supporting the efficacy and safety of flea and tick medications varies, with studies often sponsored by the companies that stand to profit from their sale. This financial connection is a conflict of interest. It can influence the outcomes and interpretations of research.
→Note: As a Cochrane review update concluded, “Drug and device studies sponsored by manufacturing companies have more favorable efficacy results and conclusions than studies sponsored by other sources.”
Importantly, even though some components of a study may be blinded, such as radiologist review of CT-based tumor (in a trial concerning cancer medications) measurements conducted through a Clinical Research Organization, product approval is still based primarily on regulatory review of sponsor-submitted data, not anonymous journal-style peer review (which, on a side note, is not necessarily bias-proof either).
More broadly, concerns about a revolving door between regulators and industry are not hypothetical; in a BMJ analysis of FDA haematology-oncology reviewers,15 of the 26 who left the agency later worked for or consulted to the biopharmaceutical industry. Moreover, the FDA’s own leadership biographies show that senior officials can come to the agency from the pharmaceutical industry, and federal ethics rules require recusal from particular matters involving a former employer for one year when a reasonable person could question the employee’s impartiality. In other words, the reviewers know which company submitted the data and which product is being evaluated, and they sometimes might have former ties to the pharmaceutical industry or an interest in joining the pharmaceutical sector. For that reason, pet owners should seek independent sources where possible and consult with their veterinarian when weighing the overall evidence.
Exploring Safer Alternatives
For those concerned about the risks of conventional medications, there are proposed alternatives, though their efficacy is mostly unproven. Natural remedies and preventive measures, such as essential oil-based products, regular grooming, and environmental controls, can reduce the need for traditional chemical treatments, but effectiveness varies, is often only anecdotal, and requires significant commitment. Therefore, these options should be discussed with a veterinarian.
Disclaimer: The information provided in this article is for educational and informational purposes only and is not intended as a substitute for advice from your veterinarian or other healthcare professional. You should not use this information to diagnose or treat a health problem or disease or prescribe any medication or other treatment. Always consult with your veterinarian or other qualified healthcare provider before making any changes to your pet's healthcare regimen, especially if they have or suspect they may have a health problem. The author and publisher of this article are not responsible for any adverse effects or consequences resulting from the use of any suggestions, products, or procedures mentioned in this article. The use of this information is at the reader's discretion and risk.
Article last updated: April 2026
Linked References
Australian Pesticides and Veterinary Medicines Authority. (n.d). Safety of fipronil in dogs and cats: a review of literature. https://www.apvma.gov.au/sites/default/files/fipronil-phase-5-prf-vol2-animal-safety-literature_0.pdf
Beier, P., Reese, S., Holler, P. J., Simak, J., Tater, G., & Wess, G. (2015). The role of hypothyroidism in the etiology and progression of dilated cardiomyopathy in Doberman Pinschers. Journal of Veterinary Internal Medicine, 29(1), 141–149. https://doi.org/10.1111/jvim.12476
Bien, J., & Prasad, V. (2016). Future jobs of FDA's haematology-oncology reviewers. BMJ (Clinical research ed.), 354, i5055. https://doi.org/10.1136/bmj.i5055
Britti, D., Marabelli, R., & Calzetta, L. (2026, April 1). Centripetal axonal transport as a gateway to the CNS for veterinary antiparasitics: Bypassing the blood–brain barrier, clinical impact in vulnerable age groups, and the potential facilitating role of PFAS, Journal of Toxicology, 1785323. https://doi.org/10.1155/jt/1785323
Bundesamt für Verbraucherschutz und Lebensmittelsicherheit (BVL). (2019, December 20). Publicly available assessment report for a veterinary medicinal product. https://www.vmd.defra.gov.uk/productinformationdatabase/files/UKPAR_Documents/UKPAR_1968830.PDF?
Boehringer Ingelheim Animal Health USA Inc. (2021). FAQs - FRONTLINE® Gold for Dogs USA. https://assets.petco.com/petco/image/upload/Frontline-Gold-Dog-US-FAQs-APPROVED.pdf
Case, K. M., Vega, N. M., Gupta, R. C., Lasher, M. A., & Canerdy, T. D. (2016). Safety Evaluation of Parastar® Plus in Dogs and Assessment of Transferable Residue of Fipronil and Cyphenothrin from Dogs to Humans. Frontiers in Veterinary Science, 3, 89. https://doi.org/10.3389/fvets.2016.00089
Companion Animal Parasite Council. (2023, March 30). CAPC guidelines. Ticks dogs. https://capcvet.org/guidelines/ticks
Cornell Richard P. Riney Canine Health Center. (n.d). Flea and tick prevention. https://www.vet.cornell.edu/departments-centers-and-institutes/riney-canine-health-center/canine-health-topics/flea-and-tick-prevention
Cornell Richard P. Riney Canine Health Center. (n.d). Anaplasmosis. https://www.vet.cornell.edu/departments-centers-and-institutes/riney-canine-health-center/canine-health-topics/anaplasmosis
Craig, M. S., Gupta, R. C., Candery, T. D., & Britton, D. A. (2005). Human exposure to imidacloprid from dogs treated with advantage(r). Toxicology mechanisms and methods, 15(4), 287–291. https://doi.org/10.1080/15376520590968842
Cribb, A. E., & Spielberg, S. P. (1990). An in vitro investigation of predisposition to sulphonamide idiosyncratic toxicity in dogs. Veterinary research communications, 14(3), 241–252. https://doi.org/10.1007/BF00347744
Drugs.com. (n.d). Advantus (imidacloprid) soft chew. https://www.drugs.com/vet/advantus-imidacloprid-soft-chew.html
Elanco. (n.d.). Seresto 8 Month Flea and Tick Collar for Dogs 38 cm – 12.5 g. https://assets.elanco.com/8e0bf1c2-1ae4-001f-9257-f2be3c683fb1/00d219d5-412a-4f57-a423-a7009319985f/Seresto_Dogs.pdf
European Commission. (2018). NexGard, INN-afoxolaner: Annex I. Summary of product characteristics [PDF]. https://ec.europa.eu/health/documents/community-register/2018/20181219142882/anx_142882_en.pdf
European Commission. (2020, April 8). Vectra 3D II-0011 - CVMP product information [PDF]. Community Register of Veterinary Medicinal Products. https://ec.europa.eu/health/documents/community-register/2020/20200408147793/anx_147793_en.pdf
European Commission. (n.d.). Advocate, INN-imidacloprid & moxidectin [PDF]. Community Register of Veterinary Medicinal Products. https://ec.europa.eu/health/documents/community-register/2004/200401058911/anx_8911_en.pdf
Forsythe, L.R., & Gollakner, R. (n.d). Imidacloprid topical. https://vcahospitals.com/know-your-pet/imidacloprid#:~:text=excessive%20drooling%20(if%20your%20pet,dogs%20taking%20Advantage%20Multi®)
Forsythe, L.R. & Gollakner, R. (n.d). Selamectin. https://vcahospitals.com/know-your-pet/selamectin#:~:text=Loss%20of%20appetite%2C%20vomiting%2C%20diarrhea,Redness
Hyland, K. (n.d). Spinosad. https://vcahospitals.com/know-your-pet/spinosad
Lau, E. (2010. Lawsuits proliferate against makers of topical flea and tick products. https://news.vin.com/default.aspx?pid=210&Id=4442412&f5=1
Lundh, A., Lexchin, J., Mintzes, B., Schroll, J. B., & Bero, L. (2018). Industry sponsorship and research outcome: systematic review with meta-analysis. Intensive care medicine, 44(10), 1603–1612. https://doi.org/10.1007/s00134-018-5293-7
Lupken, S. (2016, September 27). When drug reviewers leave the FDA, they often work for pharma. https://kffhealthnews.org/news/when-drug-reviewers-leave-the-fda-they-often-work-for-pharma/?
Miller W. H., Jr (1990). Colour dilution alopecia in Doberman Pinschers with blue or fawn coat colours: A Study on the Incidence and Histopathology of this Disorder. Veterinary Dermatology, 1(3), 113–122. https://doi.org/10.1111/j.1365-3164.1990.tb00089.x
National Pesticide Information Center. (n.d). Permethrin general fact sheet. https://npic.orst.edu/factsheets/PermGen.html
Office of Government Ethics. (2026). Personal and business relationships, 5 C.F.R. § 2635.502. Electronic Code of Federal Regulations. https://www.ecfr.gov/current/title-5/part-2635/section-2635.502
Otranto, D., de Caprariis, D., Lia, R. P., Tarallo, V., Lorusso, V., Testini, G., Dantas-Torres, F., Latrofa, S., Diniz, P. P., Mencke, N., Maggi, R. G., Breitschwerdt, E., Capelli, G., & Stanneck, D. (2010). Prevention of endemic canine vector-borne diseases using imidacloprid 10% and permethrin 50% in young dogs: a longitudinal field study. Veterinary parasitology, 172(3-4), 323–332. https://doi.org/10.1016/j.vetpar.2010.05.017
Page, S.W. (2008). Small animal clinical pharmacology (2nd ed.). Saunders. https://www.sciencedirect.com/book/edited-volume/9780702028588/small-animal-clinical-pharmacology
Rotkin-Ellmann, M. (2010, December 16). NRDC lawsuit secures warning labels for toxic flea collars in California, but nationwide ban is sorely needed. https://www.nrdc.org/bio/miriam-rotkin-ellman/nrdc-lawsuit-secures-warning-labels-toxic-flea-collars-california
Schmid, R., Brutlag, A., & Handley, H. (n.d). Pyrethrin/pyrethroid poisoning in dogs. https://vcahospitals.com/know-your-pet/pyrethrin-pyrethroid-poisoning-in-dogs#:~:text=Dogs%20that%20may%20be%20more,seizures%2C%20and%20rarely%2C%20death
Suzuki, T., Hirai, A., Khidkhan, K., Nimako, C., Ichise, T., Takeda, K., Mizukawa, H., Nakayama, S. M. M., Nomiyama, K., Hoshi, N., Maeda, M., Hirano, T., Sasaoka, K., Sasaki, N., Takiguchi, M., Ishizuka, M., & Ikenaka, Y. (2021). The effects of fipronil on emotional and cognitive behaviors in mammals. Pesticide biochemistry and physiology, 175, 104847. https://doi.org/10.1016/j.pestbp.2021.104847
Tarpataki, N., Pápa, K., Reiczigel, J., Vajdovich, P., & Vörösi, K. (2006). Prevalence and features of canine atopic dermatitis in Hungary. Acta veterinaria Hungarica, 54(3), 353–366. https://doi.org/10.1556/AVet.54.2006.3.6
United States National Library of Medicine. (2026, April 1). NEXGARD PLUS- afoxolaner, moxidectin and pyrantel tablet, chewable. DailyMed. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1eb7bc46-cac9-47d2-bbdc-6801690dfbc4
United States National Library of Medicine. (n.d.). BRAVECTO® (fluralaner topical solution) for dogs. DailyMed. https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=b4181fa7-e45f-4beb-a3f5-49c987d584ac
United States National Library of Medicine. (n.d.). REVOLUTION- selamectin solution. DailyMed. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8032a1ae-d192-4514-80f1-9a3b50dc2155
United States Environmental Protection Agency. (2011, July 28). Pesticide product label: FRONTLINE Plus for Dogs. https://www3.epa.gov/pesticides/chem_search/ppls/065331-00005-20110728.pdf
United States Food and Drug Administration. (2006, December 20). Freedom of Information summary: NADA 141-251, ADVANTAGE MULTI for Dogs, imidacloprid + moxidectin. Animal Drugs @ FDA. https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/803
United States Food and Drug Administration. (2023, August 8). Fact sheet for pet owners and veterinarians about potential adverse events associated with isoxazoline flea and tick products. https://www.fda.gov/animal-veterinary/animal-health-literacy/fact-sheet-pet-owners-and-veterinarians-about-potential-adverse-events-associated-isoxazoline-flea
United States Food and Drug Administration. (2025, January 18). Patrizia Cavazzoni, M.D. https://www.fda.gov/about-fda/center-drug-evaluation-and-research-cder/patrizia-cavazzoni
United States Environmental Protection Agency. (2016, December 1). Pesticide product label: Advantage II Large Dog. https://www3.epa.gov/pesticides/chem_search/ppls/011556-00127-20161201.pdf
United States Environmental Protection Agency. (2020, October 16). Pesticide product label: FRONTLINE Shield for Dogs. https://www3.epa.gov/pesticides/chem_search/ppls/065331-00009-20201016.pdf
United States Environmental Protection Agency. (2022, February 14). Notification per PRN 98-10 – Revise marketing claim. Product name: K9 Advantix II large dog. https://www3.epa.gov/pesticides/chem_search/ppls/011556-00143-20220214.pdf
United States Environmental Protection Agency. (2023, February 17). Whitepaper: A modern approach to EPA and FDA product oversight. https://www.epa.gov/system/files/documents/2023-02/whitepaper-a-modern-approach-epa-fda-product-oversight.pdf
University of California. (n.d). Genetic diversity testing for Doberman Pinscher. https://vgl.ucdavis.edu/sites/g/files/dgvnsk15116/files/media/documents/DobermanPinscher20230523.pdf#:~:text=Doberman%20Pinschers%20lack%20genetic%20diversity.%20yielding%20a,value%20indicates%20a%207%25%20excess%20in%20population%2D
VectraPet. (n.d.). Product inserts: Vectra® 3D for dogs.https://us.vectrapet.com/vectra-3d-for-dogs/product-inserts/
Whitehouse, T. (2021, June 7). Flea-Control products found to be infested with forever chemicals. High PFAS levels pose additional risks to pets, owners.
